Register entry
Fisher Clinical Services
- Registered sites
- 3
- Drug products
- 3
- Live patents
- 0
- Countries
- 2
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
LabellingFinished drug manufacturePackaging
Sites
Facilities
3| Site | Location | Operations | FEI |
|---|---|---|---|
| Fisher Clinical Services UK Ltd | HorshamUnited Kingdom | Packaging | 3003244526 |
| Fisher Clinical Services Inc. | Allentown, PAUnited States | Labelling, Finished drug manufacture, Packaging | 2529019 |
| Fisher Clinical Services Inc. | Breinigsville, PAUnited States | Packaging | 3007371355 |
Catalogue
Marketed products
3Showing 3 of 3.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| ZEMAIRA | alpha-1-proteinase inhibitor human kit | KIT | BLA |
| ZEMAIRA | alpha-1-proteinase inhibitor human kit | KIT | BLA |
| ZEMAIRA | alpha-1-proteinase inhibitor human kit | KIT | BLA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.